Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species

Experimental and Molecular Pathology
S Y Velda ChanDavid W Hoskin

Abstract

Strategies to promote intracellular ceramide accumulation in cancer cells may have therapeutic utility because ceramide is an important second messenger during apoptosis. Exposure to cell-permeable C(6) ceramide or tricyclodecan-9-yl-xanthate (an inducer of de novo ceramide synthesis and an inhibitor of sphingomyelin synthase) caused MDA-MB-435 human breast carcinoma cells to die by apoptosis. Concomitant treatment with the ceramidase inhibitor D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol (MAPP) or the glucosylceramide synthase inhibitor 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) potentiated the cytotoxic effect of C(6) ceramide, indicating that C(6) ceramide-mediated cytotoxicity was antagonized by the action of ceramidases and glucosylceramide synthase. Interestingly, treatment with PPMP alone, but not MAPP alone, also induced apoptosis in MDA-MB-435 cells, suggesting that conversion to glucosylceramide rather than catabolism by ceramidases prevented endogenous ceramide from reaching cytotoxic levels. C(6) ceramide-induced apoptosis in MDA-MB-435 cells was associated with the generation of reactive oxygen species, and was inhibited by the antioxidants N-acetylcysteine and glutathione. Although mitochondria...Continue Reading

References

Dec 15, 1991·Journal of Immunological Methods·P Matzinger
Oct 1, 1994·The Journal of Experimental Medicine·M G CifoneR Testi
May 24, 1996·The Journal of Biological Chemistry·A BielawskaY A Hannun
Jan 1, 1997·Toxicology and Applied Pharmacology·A H MerrillE Wang
Mar 1, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·T A Fleisher
Mar 7, 1997·Biochemical Pharmacology·L A PeñaR Kolesnick
Jul 21, 1998·Annals of the New York Academy of Sciences·S SpiegelF Wang
Aug 26, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J P JaffrézouG Laurent
Feb 26, 1999·The Journal of Biological Chemistry·P GhafourifarC Richter
Apr 14, 1999·Cell Death and Differentiation·A P BrunoJ P Jaffrézou
Feb 10, 2000·Experimental Cell Research·S S MetkarJ J Nadkarni
Jun 29, 2000·Annual Review of Biochemistry·W C EarnshawS H Kaufmann
Jun 8, 2001·Cancer Chemotherapy and Pharmacology·A G CharlesM C Cabot
Jul 14, 2001·Nature·M O Hengartner
Oct 12, 2001·Apoptosis : an International Journal on Programmed Cell Death·S Mandlekar, A N Kong
Dec 1, 2001·American Journal of Respiratory Cell and Molecular Biology·S N LavrentiadouT Goldkorn
Jan 18, 2003·Biochimica Et Biophysica Acta·Benjamin J PettusYusuf A Hannun
Jan 18, 2003·Biochimica Et Biophysica Acta·Nathalie Andrieu-Abadie, Thierry Levade
Jan 18, 2003·Biochimica Et Biophysica Acta·Richard J Bleicher, Myles C Cabot
May 6, 2003·Biochimica Et Biophysica Acta·Jennifer A Shabbits, Lawrence D Mayer
May 20, 2003·Biochemical Pharmacology·Marianne FilletMarie-Paule Merville
Jul 19, 2003·Molecular Pharmacology·Belen RamosSuzanne Jackowski
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Tom Stover, Mark Kester
Sep 18, 2003·Journal of Lipid Research·Ryan J Perry, Neale D Ridgway
Oct 18, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Francesca ScarlattiRiccardo Ghidoni
Feb 24, 2004·Journal of Cellular Physiology·Sheng ZhaoJian-Guo Song
Mar 12, 2004·Cancer Letters·C Patrick ReynoldsRichard N Kolesnick
May 8, 2004·Molecular and Cellular Endocrinology·C L ChikA K Ho
May 12, 2004·Current Drug Targets·J W Kok, H Sietsma
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang

❮ Previous
Next ❯

Citations

Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Sabrina SondaAdrian B Hehl
Jun 1, 2007·Expert Opinion on Drug Discovery·Norman S Radin
Jan 24, 2012·Neurobiology of Disease·Petr DusekWeidong Le
Sep 8, 2010·Experimental and Molecular Pathology·Azadeh Meshkini, Razieh Yazdanparast
Jan 30, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Divya VenugopalDhrubajyoti Chakravarti
Nov 24, 2007·Biochimica Et Biophysica Acta·Valérie Gouazé-AnderssonMyles C Cabot
Apr 14, 2010·Biochemical Pharmacology·Jacqueline V ChapmanMyles C Cabot
Apr 15, 2011·Journal of Lipids·Gabriella WojewodkaDanuta Radzioch
Feb 7, 2017·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Mauricio AriasHans J Vogel
Dec 22, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Sharon DeMorrowGianfranco Alpini
Nov 2, 2019·Scientific Reports·Nina SchömelMarthe-Susanna Wegner
Apr 16, 2020·International Journal of Molecular Sciences·Virginia Sara Grancieri do AmaralEleonora Kurtenbach
Oct 8, 2020·Journal of Lipid and Atherosclerosis·Makoto Taniguchi, Toshiro Okazaki
Aug 22, 2021·Cellular Signalling·Makoto Taniguchi, Toshiro Okazaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.